KaiBiLi COVID-19 Neutralization Antibody
Introductio
The KaiBiLiTMCOVID-19 Neutralization Anticorpus Rapid Test Fabrica est fluxus chromatographicus lateralis immunoassay pro detectione qualitativa neutralisationis anticorpi ad 2019-Nova Coronavirus in toto humano sanguine, serum vel plasmatis specimine.Solum adhibetur ut deprehensio referentiae indicatae ad effectum vaccini.Non convenit communi hominum protegendo.Nova coronavirorum ad β genus pertinent.
COVID-19 morbus infectious respiratorii acutus.2019-nCOV plures habet proteins structurales spicam (S), involucrum (E), membranam (M) et nucleocapsidem (N).Spicula interdum (S) receptaculum ligaturae domain (RBD) continet, quod competit agnoscere receptorem superficiei cellae, angiotensin enzyme-2 (ACE2).Inventum est RBD de 2019-nCOV S cum receptore humano ACE2 valde interacte ducens ad endocytosim in cellulas exercitus profundi pulmonis et replicationem viralem.Infectio cum MMXIX-nCOV responsionem immunem inchoat quae includit productionem elementorum in sanguine.Antibodies occultae praesidium contra futuras contagiones a virus praebent, quia in systemate circulatorio menses ad annos post infectionem manent et celeriter et fortiter ad pathogen ligabunt ad infiltration cellularum et replicationem angustos.Hae elementorum neutralisatio elementorum nominantur.
Deprehensio
Deprehensio neutralisationis anticorpi ad 2019-Novum Coronavirus in specimine humano totius sanguinis, seri vel plasmatis.
Specimen
Totum sanguinem, Serum vel Plasma specimen.
Sagaciter
Relativum Sensitivity：91.82%
Relativum Specification：99.99%
Accuracy：97.35%
Tempus proventuum
Proventus legit in 15 minuta et non plus quam 30 minuta.
Ornamentum repono conditionibus
2~30°C.
Contents
| Descriptio | P231141 | P231142. | P231143. |
| COVID-19 Neutralization Antibody test fabrica | XL PCs | XXX PCs | 1each |
| Sample quiddam | 5mL/phial(1pc) | 80μl/phial(30pcs) | 80μl/phial(30pcs) |
| Dropper capillares pro toto sanguine | XL PCs | XXX PCs | I uterque |
| sarcina inserta | I uterque | I uterque | I uterque |
Liberi Salutis lanceola et Sin codex
Informationes iussis
| Productum | Cat.No. | Contents |
| KaiBiLiTMCOVID-19 Neutralization Antibody | P231141 | 40 Test |
| KaiBiLiTMCOVID-19 Neutralization Antibody | P231142 | 30 Test |
| KaiBiLiTMCOVID-19 Neutralization Antibody | P231143 | 1 Test |
